rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-3-11
|
pubmed:abstractText |
In Australia in 1999 acellular pertussis vaccine (DTPa) replaced locally manufactured whole cell vaccine given at 2, 4 and 6 months of age with coverage of about 95% by 12 months of age. Few data are available on pertussis hospitalizations or sources of infection in countries exclusively using DTPa.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0891-3668
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
246-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15014301-Australia,
pubmed-meshheading:15014301-Bordetella pertussis,
pubmed-meshheading:15014301-Female,
pubmed-meshheading:15014301-Hospitalization,
pubmed-meshheading:15014301-Humans,
pubmed-meshheading:15014301-Infant,
pubmed-meshheading:15014301-Male,
pubmed-meshheading:15014301-Pertussis Vaccine,
pubmed-meshheading:15014301-Polymerase Chain Reaction,
pubmed-meshheading:15014301-Population Surveillance,
pubmed-meshheading:15014301-Vaccines, Acellular,
pubmed-meshheading:15014301-Whooping Cough
|
pubmed:year |
2004
|
pubmed:articleTitle |
National study of infants hospitalized with pertussis in the acellular vaccine era.
|
pubmed:affiliation |
Discipline of Paediatrics and Child Health, The University of Sydney and The Children's Hospital at Westmead, Sydney, Australia. apsu@chw.edu.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|